{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:20:35Z","timestamp":1773296435116,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.pupt.2009.08.006","type":"journal-article","created":{"date-parts":[[2009,9,7]],"date-time":"2009-09-07T04:17:00Z","timestamp":1252297020000},"page":"587-592","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease"],"prefix":"10.1016","volume":"22","author":[{"given":"Dennis E.","family":"Niewoehner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Lapidus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Cote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Sharafkhaneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Plautz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Kesten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2009.08.006_bib1","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1378\/chest.105.5.1411","article-title":"In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone","volume":"105","author":"Combivent Inhalation Aerosol Study Group","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2009.08.006_bib2","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1378\/chest.112.6.1514","article-title":"Routine nebulized ipratropium and albuterol together are better than either alone in COPD","volume":"112","author":"Combivent Inhalation Solution Study Group","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2009.08.006_bib4","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1378\/chest.126.6.1946","article-title":"Tiotropium bromide","volume":"126","author":"Gross","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2009.08.006_bib5","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/thx.2006.063271","article-title":"Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis","volume":"61","author":"Barr","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2009.08.006_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.02.00269802","article-title":"A long-term evaluation of once-daily tiotropium in chronic obstructive pulmonary disease","volume":"19","author":"Casaburi","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2009.08.006_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/thorax.58.5.399","article-title":"Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD","volume":"58","author":"Brusasco","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2009.08.006_bib8","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1378\/chest.128.3.1168","article-title":"Improvements in symptom-limited exercise performance over eight hours with once-daily tiotropium in patients with COPD","volume":"128","author":"Maltais","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2009.08.006_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-143-5-200509060-00007","article-title":"Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a long-acting inhaled anticholinergic bronchodilator. A randomized trial","volume":"143","author":"Niewoehner","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pupt.2009.08.006_bib10","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A 4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2009.08.006_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1183\/09031936.02.00238702","article-title":"Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium","volume":"19","author":"Vincken","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2009.08.006_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.pupt.2005.02.013","article-title":"Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD","volume":"18","author":"Briggs","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.pupt.2009.08.006_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1183\/09031936.05.00140404","article-title":"Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD","volume":"26","author":"van Noord","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2009.08.006_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1378\/chest.93.1.123","article-title":"Fifteen year interval spirometric evaluation of the Oregon predictive equations","volume":"93","author":"Morris","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2009.08.006_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardization of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2009.08.006_bib16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1378\/chest.115.4.957","article-title":"Efficacy of salmeterol xinafoate in the treatment of COPD","volume":"115","author":"Mahler","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2009.08.006_bib17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1164\/ajrccm.164.5.2007006","article-title":"Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease","volume":"164","author":"Dahl","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.08.006_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1183\/09031936.03.00083703","article-title":"One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease","volume":"23","author":"Oostenbrink","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2009.08.006_bib19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.clinthera.2005.05.009","article-title":"The efficacy and safety of inhaled fluticasone propionate\/salmeterol and ipratropium\/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study","volume":"27","author":"Make","year":"2005","journal-title":"Clin Ther"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109455390900100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109455390900100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T03:59:50Z","timestamp":1545019190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109455390900100X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S109455390900100X"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2009.08.006","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}